Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin

Abstract Erythropoietin (EPO), a type I cytokine originally identified for its critical role in hematopoiesis, has been shown to have non-hematopoietic, tissue-protective effects, including suppression of atherosclerosis. However, prothrombotic effects of EPO hinder its potential clinical use in non...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hiroto Ueba, Masashi Shiomi, Michael Brines, Michael Yamin, Tsutomu Kobayashi, Junya Ako, Shin-ichi Momomura, Anthony Cerami, Masanobu Kawakami
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2013-05-01
Sarja:	Molecular Medicine
Aiheet:	Helix B Surface Peptide Coronary Atherosclerotic Lesions Human Umbilical Vein Endothelial Cells (HUVECs) Antiatherosclerotic Effects Spontaneous Myocardial Infarction
Linkit:	https://doi.org/10.2119/molmed.2013.00037
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!